Christophe Giacardi
-
- Antibiotic Use and Resistance 1
-
- Diphtheria, Corynebacterium, and Tetanus 1
-
- Antibiotics Pharmacokinetics and Efficacy 2
-
- Antibiotic Resistance in Bacteria 2
-
- SARS-CoV-2 and COVID-19 Research 1
-
- COVID-19 epidemiological studies 1
-
- Airway Management and Intubation Techniques 1
-
- Pneumonia and Respiratory Infections 1
Christophe Giacardi
10 papers receiving 22 citations
Peers
Comparison fields: 5 of 32
- Applied Microbiology and Biotechnology 2
- Clinical Biochemistry 5
- Endocrinology 3
- Emergency Medical Services 4
- Pharmacology 7
Countries citing papers authored by Christophe Giacardi
This map shows the geographic impact of Christophe Giacardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Giacardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Giacardi more than expected).
Fields of papers citing papers by Christophe Giacardi
This network shows the impact of papers produced by Christophe Giacardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Giacardi. The network helps show where Christophe Giacardi may publish in the future.
Co-authorship network
The 24 scholars most cited alongside Christophe Giacardi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2021 | 1 | |
| 5 | 2016 | 1 | |
| 6 | 2016 | 2 | |
| 7 | 2015 | 1 | |
| 8 | 2015 | 0 | |
| 9 | 2011 | 4 | |
| 10 | 2011 | 4 | |
| 11 | 2010 | 2 | |
| 12 | 2009 | 4 | |
| 13 | 2009 | 2 |
About Christophe Giacardi
Christophe Giacardi is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Critical Care and Intensive Care Medicine, having authored 13 papers that have together received 23 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper), Diphtheria, Corynebacterium, and Tetanus (1 paper), COVID-19 epidemiological studies (1 paper), Airway Management and Intubation Techniques (1 paper), Pneumonia and Respiratory Infections (1 paper) and Antibiotic Use and Resistance (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (2 citations), Clinical Biochemistry (5 citations) and Endocrinology (3 citations). Christophe Giacardi has collaborated with scholars based in France. Frequent co-authors include Marc Danguy des Déserts, J. Rousset, Marc Garétier, Rafaël Mahieu, Vincent Dubée, Laurence Pougnet, M. André, Jérémie Lemarie, Cécile Aubron and Philippe Ariès. Their work appears in journals such as Anesthesia & Analgesia, Shock and Canadian Journal of Anesthesia/Journal canadien d anesthésie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.